2-190880872-CGCAGCAGCAGCAGCA-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_014905.5(GLS):c.-179_-165del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0085 in 742,618 control chromosomes in the GnomAD database, including 158 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.017 ( 56 hom., cov: 0)
Exomes 𝑓: 0.0063 ( 102 hom. )
Consequence
GLS
NM_014905.5 5_prime_UTR
NM_014905.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.335
Genes affected
GLS (HGNC:4331): (glutaminase) This gene encodes the K-type mitochondrial glutaminase. The encoded protein is an phosphate-activated amidohydrolase that catalyzes the hydrolysis of glutamine to glutamate and ammonia. This protein is primarily expressed in the brain and kidney plays an essential role in generating energy for metabolism, synthesizing the brain neurotransmitter glutamate and maintaining acid-base balance in the kidney. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 2-190880872-CGCAGCAGCAGCAGCA-C is Benign according to our data. Variant chr2-190880872-CGCAGCAGCAGCAGCA-C is described in ClinVar as [Likely_benign]. Clinvar id is 3054764.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0172 (2575/149606) while in subpopulation AFR AF= 0.0416 (1695/40698). AF 95% confidence interval is 0.04. There are 56 homozygotes in gnomad4. There are 1245 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 56 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLS | NM_014905.5 | c.-179_-165del | 5_prime_UTR_variant | 1/18 | ENST00000320717.8 | ||
LOC124906110 | XR_007087791.1 | n.758_772del | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLS | ENST00000320717.8 | c.-179_-165del | 5_prime_UTR_variant | 1/18 | 1 | NM_014905.5 | P1 | ||
GLS | ENST00000338435.9 | c.-179_-165del | 5_prime_UTR_variant | 1/15 | 1 | ||||
ENST00000413911.1 | n.829_843del | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
GLS | ENST00000479552.1 | n.35_49del | non_coding_transcript_exon_variant | 1/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0171 AC: 2564AN: 149506Hom.: 56 Cov.: 0
GnomAD3 genomes
AF:
AC:
2564
AN:
149506
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00630 AC: 3734AN: 593012Hom.: 102 AF XY: 0.00627 AC XY: 1980AN XY: 315982
GnomAD4 exome
AF:
AC:
3734
AN:
593012
Hom.:
AF XY:
AC XY:
1980
AN XY:
315982
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0172 AC: 2575AN: 149606Hom.: 56 Cov.: 0 AF XY: 0.0171 AC XY: 1245AN XY: 72924
GnomAD4 genome
AF:
AC:
2575
AN:
149606
Hom.:
Cov.:
0
AF XY:
AC XY:
1245
AN XY:
72924
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
GLS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 15, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at